← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Director Jason P Rhodes sold $181K of Replimune Group, Inc.

Sold$181,182
$41.95Price
4,319Shares
−18%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Fri, Dec 18. Filed Tue, Dec 22, 4:38 PM ET, after the close. Not investment advice.